Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Cognizant (CTSH) Set to Buy Azure Specialist 10th Magnitude

Published 09/01/2020, 09:59 PM
Updated 07/09/2023, 06:31 AM
MSFT
-
CTSH
-
CRM
-
WDAY
-

Cognizant Technology Solutions (NASDAQ:CTSH) CTSH recently announced that it has entered into an agreement to buy Chicago-based cloud firm 10th Magnitude that focuses on Microsoft’s MSFT cloud-computing arm Azure.

10th Magnitude offers advisory and managed services, including data-center transformation, application modernization, and data intelligence with AI-driven analytics and insights. Similar to Cognizant, 10th Magnitude is a Microsoft Gold Partner.

Markedly, 10th Magnitude will be integrated into Cognizant’s Microsoft Business Group upon close of the transaction, which is expected in the third quarter of 2020.

Cognizant has been focused on strengthening its footprint in Azure-related services. Notably, the company completed New Signature deal on Aug 18. The transaction expands Cognizant’s hyperscale cloud-advisory services.

Undoubtedly, the latest 10th Magnitude deal will further expand Cognizant’s Microsoft Azure expertise.

Acquisitions to Aid Cognizant’s Growth

Acquisitions have played an important part in charting out Cognizant’s growth trajectory by strengthening its digital capabilities, client base and market footprint.

In 2019, Cognizant completed five acquisitions, namely Mustache, Meritsoft, Samlink, Zenith and Contino, which expanded its footprint into SaaS, financial services including banking capabilities, biopharmaceutical and medical-device space, enterprise DevOps, and cloud transformation.

This year, the company has been particularly focusing on augmenting its cloud practices. Apart from New Signature, Cognizant bought privately held global consultancy company Collaborative Solutions, which specializes in Workday (NASDAQ:WDAY) WDAY enterprise cloud applications for financial and human resources.

Further, this Zacks Rank #3 (Hold) company bought Code Zero, a provider of consulting and implementation services that strengthens its cloud-solutions portfolio and Salesforce (NYSE:CRM) CRM domain expertise. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Additionally, Cognizant acquired Lev, a Salesforce Platinum Partner, specialized in custom cloud solutions. It also bought EI-Technologies, a digital technology consulting firm and leading Salesforce specialist.

Although the acquisitions are expected to have limited revenue contribution, they surely expand Cognizant’s digital endeavors and are expected to boost clientele in the long haul. However, acquisitions like Collaborative and New Signature are likely to keep margins under pressure in the near term.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

2020 Revenues Expected to Decline Y/Y

Markedly, for 2020, Cognizant expects revenues to decline between 0.5% and 2% year over year at constant currency to $16.4-16.7 billion range. Management anticipates its top line to suffer from the exit of certain content-services business.

Moreover, Cognizant expects adjusted operating margin to be around 15% in 2020 compared with 16.6% reported in 2019.

The Zacks Consensus Estimate for 2020 revenues is pegged at $16.56 billion, indicating a decline of 1.3% year over year. Moreover, the consensus mark for earnings stands at $3.56 per share, suggesting a decline of 10.8% year over year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microsoft Corporation (NASDAQ:MSFT): Free Stock Analysis Report

Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis Report

salesforce.com, inc. (CRM): Free Stock Analysis Report

Workday, Inc. (WDAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.